Starnberg, Germany

Juergen Kraus

This inventor holds 4 USPTO granted patents. Top assignees: 4Sc Ag, 4Sc Discovery Gmbh. Active years: 2007-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Juergen Kraus. Retrieved from https://idiyas.com/inventor/juergen-kraus-3ftow6hi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 4.6

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Starnberg, DE (2007 - 2012)
  • Andechs, DE (2020)

Company Filing History:


Years Active: 2007-2020

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Juergen Kraus: Innovator in Medical Applications

Introduction

Juergen Kraus is a notable inventor based in Starnberg, Germany. He has made significant contributions to the field of medical applications, particularly through his innovative work on Kv1.3 inhibitors. With a total of 4 patents, his research focuses on compounds that have the potential to treat various diseases.

Latest Patents

Kraus's latest patents include groundbreaking work on Kv1.3 inhibitors and their medical applications. These patents detail compounds of formula (II) or pharmaceutically acceptable salts or solvates thereof. The medical uses of these compounds are aimed at diseases or medical conditions where the inhibition of the voltage-gated potassium channel Kv1.3 is beneficial. Additionally, the patents outline methods for the preparation of these compounds, showcasing his commitment to advancing medical science.

Career Highlights

Throughout his career, Juergen Kraus has worked with prominent companies in the pharmaceutical industry, including 4SC AG and 4SC Discovery GmbH. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to the advancement of medical treatments.

Collaborations

Kraus has collaborated with several professionals in his field, including colleagues Stefan Tasler and Ilga Krimmelbein. These partnerships have played a crucial role in the development of his patents and the successful application of his research.

Conclusion

Juergen Kraus is a distinguished inventor whose work on Kv1.3 inhibitors has the potential to make a significant impact in the medical field. His innovative approach and dedication to research continue to pave the way for advancements in medical applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…